Ulf Norinder

Dr. Ulf Norinder


Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2020 in ACS Central Science
Verified
Journal Article
Closed access
FGFrancesco Gentile
Francesco Gentile
VAVibudh Agrawal
Vibudh Agrawal
MHMichael Hsing
Michael Hsing
ATAnh-Tien Ton
Anh-Tien Ton
FBFuqiang Ban
Fuqiang Ban
ACArtem Cherkasov
Artem Cherkasov

15 May 2012 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
MKMaria Karlgren
Maria Karlgren
AVAnna Vildhede
Anna Vildhede
UNUlf Norinder
Ulf Norinder
JWJacek R. Wisniewski
Jacek R. Wisniewski
EKEmi Kimoto
Emi Kimoto
PAPer Artursson
Per Artursson
The hepatic organic anion transporting polypeptides (OATPs) influence the pharmacokinetics of several drug classes and are involved in many clinical drug–drug interactions. Predicting potential interactions with OATPs is, therefore, of value. Here, we developed in vitro and in silico models for identification and prediction of specific and general inhibitors of OATP1B1, OATP1B3, and OATP2B1. The maximal transport activity (MTA) of each OATP in human liver was predicted from transport kinetics and protein quantification. We then used MTA to predict the effects of a subset of inhibitors on atorvastatin uptake in vivo. Using a data set of 225 drug-like compounds, 91 OATP inhibitors were identified. In silico models indicated that lipophilicity and polar surface area are key molecular features of OATP inhibition. MTA predictions identified OATP1B1 and OATP1B3 as major determinants of atorvastatin uptake in vivo. The relative contributions to overall hepatic uptake varied with isoform specificities of the inhibitors.

27 September 2019 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
JZJin Zhang
Jin Zhang
DMDaniel Mucs
Daniel Mucs
UNUlf Norinder
Ulf Norinder
FSFredrik Svensson
Fredrik Svensson

7 May 2009 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
PMPär Matsson
Pär Matsson
JPJenny M. Pedersen
Jenny M. Pedersen
UNUlf Norinder
Ulf Norinder
CBChristel BERGSTRÖM
Christel BERGSTRÖM
PAPer Artursson
Per Artursson

11 September 2006 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
UNUlf Norinder
Ulf Norinder
CBChristel BERGSTRÖM
Christel BERGSTRÖM

1 March 2002 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
UNUlf Norinder
Ulf Norinder
MHMarkus Haeberlein
Markus Haeberlein